{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:57:04Z","timestamp":1792720624790,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,2,1]],"date-time":"2001-02-01T00:00:00Z","timestamp":980985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1067\/msy.2001.110365","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:18:43Z","timestamp":1027556323000},"page":"176-187","source":"Crossref","is-referenced-by-count":96,"title":["Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer"],"prefix":"10.1016","volume":"129","author":[{"given":"David L.","family":"Bartlett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Libutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Figg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Fraker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.Richard","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/msy.2001.110365_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","article-title":"Cancer Statistics, 1999","volume":"49","author":"Landis","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"10.1067\/msy.2001.110365_bib2","first-page":"2551","article-title":"Metastatic cancer to the liver","author":"Daly","year":"1997"},{"key":"10.1067\/msy.2001.110365_bib3","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.1983.1.11.720","article-title":"A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma","volume":"1","author":"Lahr","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1067\/msy.2001.110365_NEWBIB1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/BF02555777","article-title":"No treatment option for liver metastases from colorectal adenocarcinoma","volume":"32","author":"Palmer","year":"1989","journal-title":"Dis Colon Rectum"},{"key":"10.1067\/msy.2001.110365_bib5","first-page":"106","article-title":"Prognosis of untreated liver metastasis from rectal cancer","volume":"36","author":"G\u00f6r\u00f6g","year":"1997","journal-title":"Acta Chir Hung"},{"key":"10.1067\/msy.2001.110365_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0011-3840(05)80012-7","article-title":"Surgical options in the treatment of hepatic metastasis from colorectal cancer","volume":"XXXII","author":"Blumgart","year":"1995","journal-title":"Curr Probl Surg"},{"key":"10.1067\/msy.2001.110365_bib7","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/bjs.1800821034","article-title":"Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer","volume":"82","author":"Rougier","year":"1995","journal-title":"Br J Surg"},{"key":"10.1067\/msy.2001.110365_bib8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/BF02553304","article-title":"Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum","volume":"25","author":"Goslin","year":"1982","journal-title":"Dis Colon Rectum"},{"key":"10.1067\/msy.2001.110365_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/lt.500050113","article-title":"Management of hepatic metastases","volume":"5","author":"Choti","year":"1999","journal-title":"Liver Transplant Surg"},{"key":"10.1067\/msy.2001.110365_bib10","first-page":"197","article-title":"Surgical treatment and other regional treatments for colorectal cancer liver metastases","volume":"4","author":"Yoon","year":"1999","journal-title":"The Oncologist"},{"key":"10.1067\/msy.2001.110365_bib11","first-page":"524","article-title":"Hepatic arterial chemotherapy in metastatic colorectal patients","volume":"26","author":"Kemeny","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1067\/msy.2001.110365_bib12","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1200\/JCO.1989.7.11.1646","article-title":"A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California oncology group trial","volume":"7","author":"Hohn","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1067\/msy.2001.110365_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7326\/0003-4819-107-4-459","article-title":"Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma","volume":"107","author":"Kemeny","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1067\/msy.2001.110365_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00000658-198712000-00001","article-title":"A prospective randomized trial of regional versus systemic continuous fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases","volume":"206","author":"Chang","year":"1987","journal-title":"Ann Surg"},{"key":"10.1067\/msy.2001.110365_bib15","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archsurg.1990.01410200086013","article-title":"Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer","volume":"125","author":"Martin","year":"1990","journal-title":"Arch Surg"},{"key":"10.1067\/msy.2001.110365_bib16","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1639::AID-CNCR1>3.0.CO;2-9","article-title":"Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver: is there a survival difference? Meta-analysis of the published literature","volume":"78","author":"Harmantas","year":"1996","journal-title":"Cancer"},{"key":"10.1067\/msy.2001.110365_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/88.5.252","article-title":"Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer","volume":"88","author":"Meta-Analysis Group in Cancer","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/msy.2001.110365_bib18","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.1994.12.11.2288","article-title":"Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma","volume":"12","author":"Kemeny","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1067\/msy.2001.110365_bib19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/bjc.1998.627","article-title":"Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases","volume":"78","author":"Fordy","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1067\/msy.2001.110365_bib20","first-page":"1","article-title":"Regional treatment strategies for unresectable primary or metastatic cancer confined to the liver","author":"Alexander","year":"1996"},{"key":"10.1067\/msy.2001.110365_bib21","first-page":"3393","article-title":"Development of a technic for isolated perfusion of the liver","volume":"61","author":"Ausman","year":"1961","journal-title":"N Y State J Med"},{"key":"10.1067\/msy.2001.110365_bib22","first-page":"2","article-title":"Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver","volume":"4","author":"Alexander","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"10.1067\/msy.2001.110365_bib23","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1200\/JCO.1998.16.4.1479","article-title":"Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver","volume":"16","author":"Alexander","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1067\/msy.2001.110365_bib24","first-page":"141","article-title":"Isolated perfusion of the liver","author":"Fraker","year":"1997"},{"key":"10.1067\/msy.2001.110365_bib25","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/BF00801607","article-title":"Continuous intraoperative external monitoring of perfusate leak using I-131 human serum albumin during isolated perfusion of the liver and limbs","volume":"22","author":"Barker","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1067\/msy.2001.110365_bib26","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V89.5.1501","article-title":"Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients","volume":"89","author":"Bearman","year":"1997","journal-title":"Blood"},{"key":"10.1067\/msy.2001.110365_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bjc.1992.235","article-title":"The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma","volume":"68","author":"Scott","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1067\/msy.2001.110365_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1200\/JCO.1995.13.1.264","article-title":"Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion (ILP) with high-dose TNF, interferon-gamma and melphalan","volume":"13","author":"Thom","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1067\/msy.2001.110365_bib29","first-page":"571","article-title":"Die isolierte leberperfusion mit 5-fluorouracil (5-FU) beim menschen","volume":"53","author":"Aigner","year":"1982","journal-title":"Chirurg"},{"key":"10.1067\/msy.2001.110365_bib30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/BF01655820","article-title":"Rationale and indications for perfusion in liver tumors: current data","volume":"11","author":"Schwemmle","year":"1987","journal-title":"World J Surg"},{"key":"10.1067\/msy.2001.110365_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.jjco.a023243","article-title":"Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver","volume":"26","author":"Marinelli","year":"1996","journal-title":"Jpn J Clin Oncol"},{"key":"10.1067\/msy.2001.110365_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0960-7404(94)90005-1","article-title":"Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy","volume":"3","author":"Hafstr\u00f6m","year":"1994","journal-title":"Surg Oncol"},{"key":"10.1067\/msy.2001.110365_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/ejso.1998.0623","article-title":"Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia tumour necrosis factor alpha and melphalan","volume":"25","author":"Lindner","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"10.1067\/msy.2001.110365_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-642-80460-1_11","article-title":"Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans","volume":"147","author":"de Vries","year":"1998","journal-title":"Recent Results Cancer Res"},{"key":"10.1067\/msy.2001.110365_bib35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0039-6060(98)70200-4","article-title":"First experience and technical aspects of isolated liver perfusion for extensive liver metastasis","volume":"123","author":"Oldhafer","year":"1998","journal-title":"Surgery"},{"key":"10.1067\/msy.2001.110365_bib36","first-page":"222","article-title":"Clinical results of hyperthermic liver perfusion for cancer in the liver","author":"Skibba","year":"1988"},{"key":"10.1067\/msy.2001.110365_bib37","first-page":"396","article-title":"Hyperthermic isolated limb perfusion (HILP) with tumor necrosis factor (TNF) alone for metastatic intransit melanoma [abstract]","volume":"13","author":"Posner","year":"1994","journal-title":"ASCO"},{"key":"10.1067\/msy.2001.110365_bib38","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/0003-4975(96)00166-X","article-title":"Isolated lung perfusion with tumor necrosis factor for pulmonary metastases","volume":"61","author":"Pass","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1067\/msy.2001.110365_bib39","first-page":"174","article-title":"Tumor necrosis factor: basic principles and clinical application in systemic and regional cancer treatment","author":"Alexander","year":"2000"},{"key":"10.1067\/msy.2001.110365_bib40","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1084\/jem.163.6.1363","article-title":"Tumor necrosis factor\/cachectin interacts with endothelial cell receptors to induce release of interleukin 1","volume":"163","author":"Nawroth","year":"1986","journal-title":"J Exp Med"},{"key":"10.1067\/msy.2001.110365_bib41","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.169.6.1977","article-title":"Tumor necrosis factor\/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins","volume":"169","author":"Brett","year":"1989","journal-title":"J Exp Med"},{"key":"10.1067\/msy.2001.110365_bib42","first-page":"2357","article-title":"Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor independent mechanisms","volume":"4","author":"Alexander","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1067\/msy.2001.110365_bib43","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1200\/JCO.1986.4.11.1586","article-title":"Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma","volume":"4","author":"Leff","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1067\/msy.2001.110365_bib44","first-page":"947","article-title":"Update on hepatic intra-arterial chemotherapy","volume":"11","author":"Venook","year":"1997","journal-title":"Oncology"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003960600188569X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003960600188569X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T21:51:39Z","timestamp":1576446699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003960600188569X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["S003960600188569X"],"URL":"https:\/\/doi.org\/10.1067\/msy.2001.110365","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2]]}}}